An Assessment of MT1A (rs11076161), MT2A (rs28366003) and MT1L (rs10636) Gene Polymorphisms and MT2 Concentration in Women with Endometrial Pathologies
Genes · 2023
DOI: 10.3390/genes14030773 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2023. Verfasst von Kaja Michalczyk und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University in Szczecin, 70-111 Szczecin,…. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide, Endometrial Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Several studies have indicated a relationship between metallothionein (MT) polymorphisms and the development of different pathologies, including neoplastic diseases. However, no studies thus far have been conducted on the influence of MT polymorphisms and the development of endometrial lesions, including endometrial cancer. This study included 140 patients with normal endometrial tissue, endometrial polyps, uterine myomas and endometrial cancer. The tissue MT2 concentration was determined using the ELISA method. MT1A, MT2A and MT1L polymorphisms were analyzed using TaqMan real-time PCR genotyping assays. We found no statistical difference between the tissue MT2 concentration in patients with EC vs. benign endometrium (p = 0.579). However, tissue MT2 concentration was significantly different between uterine fibromas and normal endometrial tissue samples (p = 0.019). Menopause status did not influence the tissue MT2 concentration (p = 0.282). There were no significant associations between the prevalence of MT1A, MT2A and MT1L polymorphisms and MT2 concentration. The age, menopausal status, and diabetes status of patients were identified as EC risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.
- Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, Powstańców Wlkp. 72, 70-111 Szczecin, Poland.
- Department of Obstetrics and Gynecology, Pomeranian Medical University, Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.
- Department of Functional Diagnostics and Physical Medicine, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.
- Department of Experimental and Clinical Pharmacology, Pomeranian Medical University in Szczecin, Powstancow Wielkopolskich 72, 70-111 Szczecin, Poland.
- Department of Reconstructive Surgery and Gynecological Oncology, Pomeranian Medical University in Szczecin, Al. Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.
ORCID-Profile: Kaja Michalczyk, Patrycja Kapczuk, Dariusz Chlubek, Aneta Cymbaluk-Płoska
Zitieren
APA
Michalczyk, K., Kapczuk, P., Witczak, G., Tousty, P., Bosiacki, M., Kurzawski, M., Chlubek, D., & Cymbaluk-Płoska, A. (2023). An Assessment of MT1A (rs11076161), MT2A (rs28366003) and MT1L (rs10636) Gene Polymorphisms and MT2 Concentration in Women with Endometrial Pathologies. Genes. https://doi.org/10.3390/genes14030773
Vancouver
Michalczyk K, Kapczuk P, Witczak G, Tousty P, Bosiacki M, Kurzawski M, et al. An Assessment of MT1A (rs11076161), MT2A (rs28366003) and MT1L (rs10636) Gene Polymorphisms and MT2 Concentration in Women with Endometrial Pathologies. Genes. 2023. doi:10.3390/genes14030773
BibTeX
@article{Michalczyk2023,
author = {Michalczyk, Kaja and Kapczuk, Patrycja and Witczak, Grzegorz and Tousty, Piotr and Bosiacki, Mateusz and Kurzawski, Mateusz and Chlubek, Dariusz and Cymbaluk-Płoska, Aneta},
title = {An Assessment of MT1A (rs11076161), MT2A (rs28366003) and MT1L (rs10636) Gene Polymorphisms and MT2 Concentration in Women with Endometrial Pathologies},
journal = {Genes},
year = {2023},
doi = {10.3390/genes14030773}
}
EUVIMED